With continuous glucose monitors, students with Type 1 diabetes no longer have to visit the school nurse for a finger prick.

Medicine and Gonzaga University will host a panel featuring experts on diabetes to discuss new developments in glucose monitoring strategies.

Samsung might be the first to crack the non-invasive blood glucose monitoring code, but gaining FDA approval will be the ...

Shares of Trinity Biotech climbed after the company released what it called compelling results from a study of its next-generation continuous glucose monitoring system, a device used for diabetes ...

Trinity Biotech (TRIB) stock gains on encouraging data from a pre-pivotal clinical trial for its next-gen continuous glucose ...

Looking to beat cravings, manage blood sugar levels and shed pounds? Georgetown University–trained biochemist Jessie ...

Trinity stock is trading higher on Tuesday after the company announced results from its pre-pivotal clinical trial for its ...

DUBLIN - Trinity Biotech plc (NASDAQ:TRIB), an Ireland-based biotech firm with a market capitalization of $13.24 million, revealed promising results from a recent pre-pivotal clinical trial for its ...

Trinity Biotech (TRIB) announced results from its latest pre-pivotal clinical trial for its next-generation continuous glucose monitoring ...

Samsung hints at a game-changing non-invasive blood glucose monitor for a future Galaxy Watch, potentially revolutionizing ...

Continuous glucose monitors like Dexcom's Stelo and Abbott's Lingo are small, wearable devices that track blood glucose ...